CLOVER BIOPHARMACEUTICALS AUS PTY LTD

Lumley Hse L 11 309 Kent St, Sydney, New South Wales, Australia

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

52.9%

Phase 3

29.4%

Phase 2

17.6%

Trial Status Distribution

Active, not recruiting

5.9%

Completed

47.1%

Not yet recruiting

5.9%

Terminated

5.9%

Withdrawn

35.3%

Clinical Trials

Trials sponsored by this organization (17)

Safety and Immunogenicity Study of SCB-1019T in Children

Phase 1

Withdrawn

interventional

Oct 2025112 participants

First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults

Phase 1

Completed

interventional

Dec 2023160 participants

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults

Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

Phase 3

Completed

interventional

Jun 20221,831 participants

Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults

Phase 1

Completed

interventional

May 2022153 participants

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations